HLA-C and cancer: Furthermore, this study also showed the limitations of mutated CD4 and CD8 neoepitopes for cancer surveillance: although these epitopes where high affinity binders to their MHC molecule and responded well upon application of immunotherapies in corresponding parental cell lines, the host’s immune system failed to mount an immune response able to inhibit cancer outgrowth.